RecallDepth
Class III Terminated

Bevacizumab 2.5 mg/0.1 mL, Solution for Injection in 1mL, silicone free slip tip syringe, each Syringe supplied in individually labeled poly envelopes (primary packaging). Repackaged by Pine Pharmaceuticals, Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150, Office Use Only, Not for Resale. Secondary packaging consists of a coated cardboard box, with order-specific label indicating lot number housed within order/container. NDC # 69194-0458-1

Company
Pine Pharmaceuticals, Llc
Recall Initiated
March 27, 2023
Posted
April 19, 2023
Recall Number
D-0531-2023
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
932 syringes
Firm Location
Tonawanda, NY, United States

Reason for Recall

Labeling: Incorrect or Missing Lot and/or Exp Date: Lot code on primary packaging is incorrect.

Distribution

Nationwide in the USA

Lot / Code Info

Lot # 66377, Exp. Date: 06/28/2023. Syringe may be labeled incorrectly as lot# 66316

More recalls by Pine Pharmaceuticals, Llc

View all recalls by this company →

Other recent Class III Drug recalls